Analysis of the Risk of COVID-19 in the Post-Vaccination Period Based on the Results of a Multicenter Study — a Survey of Medical Workers
Article in Annals of the Russian academy of medical sciences (February 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Longitudinal study of immunity to SARS-CoV2 in Ocrelizumab-treated multiple sclerosis patients up to 2 years after COVID-19 vaccination
Preprint in medRxiv (January 2024)
Immunogenicity and safety of vaccines in multiple sclerosis: A systematic review and meta-analysis
Article in Journal of the Neurological Sciences (December 2023)